J&J | JNJ - Beneficio Operativo





Beneficio Operativo Cambio Fecha
AbbVie USD 6.72B 1.99B 2026-06
Abbott USD 2.13B 281M 2026-06
Amgen USD 4.61B 777M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Baxter International USD 276M 210M 2026-06
Bayer EUR 827M 2.7B 2026-06
Becton, Dickinson and Co. USD 752M 125M 2026-06
Biogen USD -243.8M 758.1M 2026-06
Boston Scientific USD 1.24B 190M 2026-06
Bristol-Myers Squibb USD 299M 3.07B 2026-06
CONMED USD 36.4M 10.99M 2026-06
Cooper Companies USD -31M 243.8M 2026-03
Dexcom USD 318.3M 63M 2026-06
Edwards Lifesciences USD 519.5M 4.8M 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Globus Medical USD -45.97M 209.97M 2026-06
Insulet USD 129.7M 7.7M 2026-06
Integra LifeSciences USD 41.29M 29.82M 2026-06
Intuitive Surgical USD 977.6M 117.9M 2026-06
J&J USD 7.48B 860M 2026-06
Medtronic USD 2.09B 354M 2026-03
Merck USD 840M 2.72B 2026-06
Merit Medical Systems USD 60.4M 16.25M 2026-06
Novartis USD 4.75B 515M 2026-06
Pfizer USD 667M 4.32B 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 2.38B 449M 2026-06
Stryker USD 1.79B 687M 2026-06
Tandem Diabetes Care USD -13.79M 3.64M 2026-06
Teva Pharmaceutical Industries USD 235M 523M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06
Zimmer Biomet Holdings USD 344.7M 50.4M 2026-06
Zoetis USD 1.12B 256M 2026-06